PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 药石科技2026年第一次临时股东会法律意见书 | 2026-02-02 | Chinese | |
| 关于变更注册资本、修订《公司章程》暨授权办理工商变更登记的公告 | 2026-01-15 | Chinese | |
| 关于召开2026年第一次临时股东会的通知 | 2026-01-15 | Chinese | |
| 公司章程（2026年1月） | 2026-01-15 | Chinese | |
| 华泰联合证券有限责任公司关于南京药石科技股份有限公司变更部分募集资金用途暨新增募集资金投资项目的核查意见 | 2026-01-15 | Chinese | |
| 第四届董事会第十二次会议决议公告 | 2026-01-15 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 40025045 | 药石科技2026年第一次临时股东会法律意见书 | 2026-02-02 | Chinese | ||
| 40025036 | 关于变更注册资本、修订《公司章程》暨授权办理工商变更登记的公告 | 2026-01-15 | Chinese | ||
| 40025028 | 关于召开2026年第一次临时股东会的通知 | 2026-01-15 | Chinese | ||
| 40024975 | 公司章程（2026年1月） | 2026-01-15 | Chinese | ||
| 40024962 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司变更部分募集资金用途暨新增募集资金投资项目的核查意见 | 2026-01-15 | Chinese | ||
| 40024897 | 第四届董事会第十二次会议决议公告 | 2026-01-15 | Chinese | ||
| 40024888 | 关于变更部分募集资金用途暨新增募集资金投资项目的公告 | 2026-01-15 | Chinese | ||
|
2025
8 filings
| |||||
| 40024886 | 关于股东减持股份计划实施完成的公告 | 2025-12-23 | Chinese | ||
| 40024878 | 内部审计制度 | 2025-10-29 | Chinese | ||
| 40024870 | 2025年三季度报告 | 2025-10-29 | Chinese | ||
| 40024852 | 第四届董事会第十一次会议决议公告 | 2025-10-29 | Chinese | ||
| 40024850 | 关于股东减持股份计划实施完成的公告 | 2025-09-29 | Chinese | ||
| 40024847 | 关于控股股东、实际控制人及其一致行动人权益变动触及1%整数倍的公告 | 2025-09-26 | Chinese | ||
| 40024844 | 关于药石转债赎回结果的公告 | 2025-09-25 | Chinese | ||
| 40024842 | 关于药石转债摘牌的公告 | 2025-09-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.